Genezen News and Resources

Genezen, a gene therapy CDMO, has announced an agreement to acquire uniQure’s commercial gene therapy operations in Lexington, MA. The acquisition includes a state-of-the-art manufacturing facility and a world-class team of employees. This transaction will enable Genezen to enhance its

Genezen, a prominent player in the cell and gene therapy Contract Development and Manufacturing Organisation (CDMO) sector, announced today that it has licensed the Cytegrity™ proprietary stable production system from biotechnology leader CSL.  The Cytegrity™ system is an advanced inducible